BCL6 and gastric cancer: On the basis of these results, we speculate that in undifferentiated gastric cancers, the degradation of BCL6 induces cell-cycle acceleration through cyclin D2 expression and that this cell-cycle acceleration might be associated with undifferentiated gastric cancers.